Items where Author is "Barabas, S."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 13.

Article

Barabas, S. and Zeman, F. and Pfister, A. and Bendfeldt, H. and Starke, A. and Jilg, W. and Wolf, H. and Koller, M. and Banas, B. and Kraemer, B. K. and Deml, L. (2011) IMMUNE MONITORING WITH UREA-FORMULATED EBV PROTEINS FOR PREDICTION OF EBV REACTIVATION IN RENAL TRANSPLANT PATIENTS. TRANSPLANT INTERNATIONAL, 24 (Suppl3). p. 57. ISSN 0934-0874

Barabas, S. and Spindler, T. and Tonar, C. and Jilg, W. and Koller, M. and Wolff, D. and Holler, E. and Banas, B. and Deml, L. (2011) UREA-FORMULATED PROTEINS: A NOVEL TOOL FOR IMPROVED MONITORING OF VIRUS SPECIFIC CELL MEDIATED IMMUNE RESPONSES IN TRANSPLANT PATIENTS. TRANSPLANT INTERNATIONAL, 24 (suppl3). p. 55. ISSN 0934-0874

Schneider, N. and Mueller, C. and Barabas, S. and Lindner, J. and Altmann, D. and Wolf, W. and Schölmerich, J. and Fleck, M. and Deml, L. (2007) The role of CD40/CD40 ligand interactions in the expression of OX40 ligand and 4.1 BB ligand in antigen presenting cells. ZEITSCHRIFT FUR RHEUMATOLOGIE, 66 (Suppl1). p. 46. ISSN 0340-1855

Other

Banas, B. and Steubl, D. and Renders, L. and Chittka, D. and Banas, M. and Wekerle, T. and Koch, M. and Witzke, O. and Muehlfeld, A. and Sommerer, C. and Habicht, A. and Hugo, C. and Huenig, T. and Lindemann, M. and Schmidt, T. and Rascle, A. and Eder, K. and Barabas, S. and Deml, L. and Wagner, R. and Kraemer, B. and Krueger, B. (2018) CLINICAL VALIDATION OF A NOVEL ELISPOT-BASED IN VITRO DIAGNOSTIC ASSAY TO MONITOR CMV-SPECIFIC CELL-MEDIATED IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS. WILEY, HOBOKEN.

Banas, B. and Steubl, D. and Renders, L. and Chittka, D. and Banas, M. and Wekerle, T. and Koch, M. and Witzke, O. and Muehlfeld, A. and Sommerer, C. and Habicht, A. and Hugo, C. and Huenig, T. and Lindemann, M. and Schmidt, T. and Rascle, A. and Barabas, S. and Deml, L. and Wagner, R. and Kraemer, B. and Krueger, B. (2017) CLINICAL VALIDATION OF A NOVEL ELISPOT-BASED IN VITRO DIAGNOSTIC ASSAY TO MONITOR CMV-SPECIFIC CELL-MEDIATED IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS. WILEY, HOBOKEN.

Banas, B. and Steubl, D. and Renders, L. and Wekerle, T. and Koch, M. and Witzke, O. and Muehlfeld, A. and Sommerer, C. and Habicht, A. and Hugo, C. and Huenig, T. and Lindemann, M. and Barabas, S. and Deml, L. and Wagner, R. and Krueger, B. (2016) CLINICAL VALIDATION OF T-TRACK (R) CMV TO ASSESS THE FUNCTIONALITY OF CMV-SPECIFIC CELL-MEDIATED IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS. WILEY, HOBOKEN.

Banas, B. and Boeger, C. and Lueckhoff, G. and Krueger, B. and Barabas, S. and Starke, A. and Schemmerer, M. and Rascle, A. and Koestler, J. and Wagner, R. and Deml, L. and Leicht, J. and Kraemer, B. (2016) VALIDATION OF A NOVEL CYTOMEGALOVIRUS-SPECIFIC ELISPOT ASSAY TO MONITOR THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY IN HEMODIALYSIS PATIENTS. WILEY, HOBOKEN.

Asbach-Nitzsche, A. and Barabas, S. and Drexler, K. and Fleck, M. and Avsar, K. and Boeckl, K. and Reuter, M. and Koestler, J. and Blaas, S. and Deml, L. (2015) A NOVEL STRATEGY FOR THE DETECTION OF ACTIVE TUBERCULOSIS. WILEY-BLACKWELL, HOBOKEN.

Barabas, S. and Spindler, T. and Tonar, C. and Widmann, T. and Batzilla, J. and Boeckl, K. and Deml, L. (2015) AN OPTIMIZED ELISPOT ASSAY TO DETERMINE CMV PROTEIN-REACTIVE CELLS OF CELL-MEDIATED IMMUNITY. WILEY-BLACKWELL, HOBOKEN.

Banas, B. and Boeger, C. and Lueckhoff, G. and Krueger, B. and Boeckl, K. and Batzilla, J. and Bendfeldt, H. and Schemmerer, M. and Koestler, J. and Barabas, S. and Wagner, R. and Deml, L. and Leicht, J. and Kraemer, B. K. (2015) VALIDATION OF THE SUITABILITY OF A NOVEL ELISPOT ASSAY TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS. WILEY, HOBOKEN.

Deml, L. and Barabas, S. and Zeman, F. and Bendfeldt, H. and Starke, A. and Pfister, A. and Krueger, B. and Jilg, W. and Wolf, H. and Koller, M. and Kraemer, B. K. and Banas, B. (2014) A PILOT STUDY IN KIDNEY TRANSPLANT RECIPIENTS TO ASSESS THE SUITABILITY OF ACTIVATED BZLF1 FOR THE MONITORING OF EBV-SPECIFIC CELLULAR IMMUNITY. WILEY-BLACKWELL, HOBOKEN.

Banas, B. and Boeger, C. and Lueckhoff, G. and Krueger, B. and Starke, A. and Bendfeldt, H. and Batzilla, J. and Schemmerer, M. and Koestler, J. and Barabas, S. and Wagner, R. and Deml, L. and Leicht, J. and Kraemer, B. K. (2014) VALIDATION OF THE SUITABILITY OF LOPHIUS BIOSCIENCES T-TRACK (R) CMV TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS. WILEY-BLACKWELL, HOBOKEN.

["eprint_typename_meeting" not defined]

Banas, B. and Steubl, D. and Renders, L. and Chittka, D. and Banas, M. and Wekerle, T. and Koch, M. and Witzke, O. and Muehlfeld, A. and Sommerer, C. and Habicht, A. and Hugo, C. and Huenig, T. and Lindemann, M. and Schmidt, T. and Rascle, A. and Barabas, S. and Deml, L. and Wagner, R. and Kraemer, B. and Krueger, B. (2018) Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients. [["eprint_typename_meeting" not defined]]

This list was generated on Thu Sep 24 09:04:55 2026 CEST.